Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FACE study in children
2024-513430-37-00Phase 4Authorised
- Sponsor
- Region Dalarna
- Start
- May 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in facial palsy comparing Prednisolone with Placebo (2 arms). Primary endpoint: Total recovery of facial nerve palsy at 12 months by House-Brackmann scale. Planned start May 2024; status: authorised.
02
Drugs
prednisolone
03
Conditions
facial palsy
Beyond the preview
Go deeper on 2024-513430-37-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-513430-37-00.